AMGN vs REFR · P/E 24, rev $10.05B vs rev $222.7K
Amgen Inc (AMGN) versus Research Frontiers Incorporated (REFR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Research Frontiers Incorporated (REFR) is a electronic components company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported REFR revenue for 2026-06-30 was $222.7K. Net income was -$1.2M. Revenue was up 63.3% from 2026-03-31 to 2026-06-30. REFR currently screens at market cap $22.4M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. REFR currently screens at market cap $22.4M.
Not investment advice. Open the AMGN and REFR stock pages for the full models.
Not investment advice.